Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Rappl, G; Abken, H; Hasselmann, DO; Tilgen, W; Ugurel, S; Reinhold, U
   The CD7(-) subset of CD4(+) memory T cells is prone to accelerated apoptosis that is prevented by interleukin-15 (IL-15)
   CELL DEATH AND DIFFERENTIATION
   
   G. Rappl et al., "The CD7(-) subset of CD4(+) memory T cells is prone to accelerated apoptosis that is prevented by interleukin-15 (IL-15)", CELL DEAT D, 8(4), 2001, pp. 395-402
2. Narla, RK; Chen, CL; Dong, YH; Uckun, FM
   In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) {METVAN [VO(SO4)(Me-2-Phen)(2)]}
   CLINICAL CANCER RESEARCH
   
   R.K. Narla et al., "In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) {METVAN [VO(SO4)(Me-2-Phen)(2)]}", CLIN CANC R, 7(7), 2001, pp. 2124-2133
3. Erickson, HA; Reinhardt, RL; Hermanson, JB; Panoskaltsis-Mortari, A; Pennell, CA
   Visualization of immunotoxin-mediated tumor cell death in vivo
   CLINICAL CANCER RESEARCH
   
   H.A. Erickson et al., "Visualization of immunotoxin-mediated tumor cell death in vivo", CLIN CANC R, 7(3), 2001, pp. 890S-894S
4. Al Saati, T; Alibaud, L; Lamant, L; Boyes, J; March, M; Delsol, G
   A new monoclonal anti-CD7 antibody reactive on paraffin sections
   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
   
   T. Al Saati et al., "A new monoclonal anti-CD7 antibody reactive on paraffin sections", APPL IMMUNO, 9(4), 2001, pp. 289-296
5. Otsuki, T; Wada, H; Nakazawa, N; Taniwaki, M; Kouguchi, K; Ohkura, M; Uehira, K; Isoda, K; Yata, K; Sakaguchi, H; Yawata, Y; Ueki, A; Yamada, O
   Establishment of CD7(+) human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14)
   LEUKEMIA & LYMPHOMA
   
   T. Otsuki et al., "Establishment of CD7(+) human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14)", LEUK LYMPH, 42(4), 2001, pp. 761
6. Tanaka, M; Kanamori, H; Yamaji, S; Fujimaki, K; Tomita, N; Fujisawa, S; Ishigatsubo, Y
   Therapy-related CD7(+) acute myeloid leukemia with trisomy 8 following acute monocytic leukemia
   ANTI-CANCER DRUGS
   
   M. Tanaka et al., "Therapy-related CD7(+) acute myeloid leukemia with trisomy 8 following acute monocytic leukemia", ANTI-CANC D, 12(8), 2001, pp. 681-682
7. Kahl, C; Pelz, AF; Bartsch, R; Jentsch-Ullrich, K; Bruckner, R; Fostitsch, HP; Franke, A
   Myeloid/natural killer cell precursor blast crisis of chronic myelogenous leukemia with two Philadelphia (Ph-1) chromosomes
   ANNALS OF HEMATOLOGY
   
   C. Kahl et al., "Myeloid/natural killer cell precursor blast crisis of chronic myelogenous leukemia with two Philadelphia (Ph-1) chromosomes", ANN HEMATOL, 80(1), 2001, pp. 58-61
8. Rossi, M; Camera, A; Barone, M; Castagnola, C; Del Vecchio, L; Rotoli, B
   CD7(+) acute leukemia switching from a lymphoid to a myeloid phenotype
   HAEMATOLOGICA
   
   M. Rossi et al., "CD7(+) acute leukemia switching from a lymphoid to a myeloid phenotype", HAEMATOLOG, 86(8), 2001, pp. 877-877
9. van Oosterhout, YVJM; van Emst, JL; Bakker, HH; Preijers, FWMB; Schattenberg, AVMB; Ruiter, DJ; Evers, S; Koopman, JP; de Witte, T
   Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot study
   INTERNATIONAL JOURNAL OF PHARMACEUTICS
   
   Y.V.J.M. van Oosterhout et al., "Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot study", INT J PHARM, 221(1-2), 2001, pp. 175-186
10. Stillwell, R; Bierer, BE
    T cell signal transduction and the role of CD7 in costimulation
    IMMUNOLOGIC RESEARCH
    
    R. Stillwell e B.E. Bierer, "T cell signal transduction and the role of CD7 in costimulation", IMMUNOL RES, 24(1), 2001, pp. 31-52
11. Kondo, H; Kobayashi, A; Iwasaki, H
    Trisomy 21 as the sole acquired karyotypic abnormality in an adult patientwith CD7-positive acute myeloid leukemia
    CANCER GENETICS AND CYTOGENETICS
    
    H. Kondo et al., "Trisomy 21 as the sole acquired karyotypic abnormality in an adult patientwith CD7-positive acute myeloid leukemia", CANC GENET, 127(1), 2001, pp. 77-79
12. Blindauer, CA; Harrison, MD; Parkinson, JA; Robinson, AK; Cavet, JS; Robinson, NJ; Sadler, PJ
    A metallothionein containing a zinc finger within a four-metal cluster protects a bacterium from zinc toxicity
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    C.A. Blindauer et al., "A metallothionein containing a zinc finger within a four-metal cluster protects a bacterium from zinc toxicity", P NAS US, 98(17), 2001, pp. 9593-9598
13. Bernengo, MG; Novelli, M; Quaglino, P; Lisa, F; De Matteis, A; Savoia, P; Cappello, N; Fierro, MT
    The relevance of the CD4+CD26-subset in the identification of circulating Sezary cells
    BRITISH JOURNAL OF DERMATOLOGY
    
    M.G. Bernengo et al., "The relevance of the CD4+CD26-subset in the identification of circulating Sezary cells", BR J DERM, 144(1), 2001, pp. 125-135
14. Karandikar, NJ; Aquino, DB; McKenna, RW; Kroft, SH
    Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome - An immunophenotypic analysis
    AJCP. American journal of clinical pathology
    
    N.J. Karandikar et al., "Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome - An immunophenotypic analysis", AM J CLIN P, 116(2), 2001, pp. 204-210
15. Tokunaga, Y; Miyamoto, T; Gondo, H; Okamura, T; Niho, Y
    Effect of thrombopoietin on acute myelogenous leukemia blasts
    LEUKEMIA & LYMPHOMA
    
    Y. Tokunaga et al., "Effect of thrombopoietin on acute myelogenous leukemia blasts", LEUK LYMPH, 37(1-2), 2000, pp. 27-37
16. Rubio-Batlles, M; de la Mata, AC; Macias, JRR; Vitaller, AR
    Isolated asymptomatic severe neutropenia as the presentation of myelold/natural killer cell acute leukemia
    HAEMATOLOGICA
    
    M. Rubio-Batlles et al., "Isolated asymptomatic severe neutropenia as the presentation of myelold/natural killer cell acute leukemia", HAEMATOLOG, 85(3), 2000, pp. 322-324
17. Kahl, C; Florschutz, A; Jentsch-Ullrich, K; Dietzmann, K; Franke, A
    Primary intracranial manifestation of CD7/CD56-positive acute myelogenous leukemia
    ONKOLOGIE
    
    C. Kahl et al., "Primary intracranial manifestation of CD7/CD56-positive acute myelogenous leukemia", ONKOLOGIE, 23(6), 2000, pp. 580-582
18. Nakase, K; Hasegawa, M; Tsuji, K; Ikeda, T; Tamaki, S; Tanigawa, R; Miyanishi, E; Shiku, H
    HTLV-1 unrelated adult T-cell leukemia/lymphoma with unique phenotype and karyotype
    AMERICAN JOURNAL OF HEMATOLOGY
    
    K. Nakase et al., "HTLV-1 unrelated adult T-cell leukemia/lymphoma with unique phenotype and karyotype", AM J HEMAT, 64(1), 2000, pp. 64-66
19. de Vries, E; van Tol, MJD; van den Bergh, RL; Waaijer, JLM; ten Dam, MM; Hermans, J; Vossen, JM
    Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    E. de Vries et al., "Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation", BONE MAR TR, 25(3), 2000, pp. 267-275
20. Szilagyi, Z; Fenselau, C
    Molecular dynamics simulation of metallothionein-drug complexes
    DRUG METABOLISM AND DISPOSITION
    
    Z. Szilagyi e C. Fenselau, "Molecular dynamics simulation of metallothionein-drug complexes", DRUG META D, 28(2), 2000, pp. 174-179
21. Laetsch, B; Haffner, AC; Dobbeling, U; Seifert, B; Ludwig, E; Burg, G; Dummer, R
    CD4+/CD7(-) T cell frequency and polymerase chain reaction-based clonalityassay correlate with stage in cutaneous T cell lymphomas
    JOURNAL OF INVESTIGATIVE DERMATOLOGY
    
    B. Laetsch et al., "CD4+/CD7(-) T cell frequency and polymerase chain reaction-based clonalityassay correlate with stage in cutaneous T cell lymphomas", J INVES DER, 114(1), 2000, pp. 107-111
22. Lyman, SD; Escobar, S; Rousseau, AM; Armstrong, A; Fanslow, WC
    Identification of CD7 as a cognate of the human K12 (SECTM1) protein
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S.D. Lyman et al., "Identification of CD7 as a cognate of the human K12 (SECTM1) protein", J BIOL CHEM, 275(5), 2000, pp. 3431-3437
23. Wallace, DL; Matear, PM; Davies, DC; Hicks, R; Lebosse, C; Eyeson, J; Beverley, PCL; Vyakarnam, A
    CD7 expression distinguishes subsets of CD4(+) T cells with distinct functional properties and ability to support replication of HIV-1
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    D.L. Wallace et al., "CD7 expression distinguishes subsets of CD4(+) T cells with distinct functional properties and ability to support replication of HIV-1", EUR J IMMUN, 30(2), 2000, pp. 577-585
24. Hamalainen, MM; Eskola, JU; Hellman, J; Pulkki, K; Rajamaki, A
    RT-PCR from eosinophil-depleted leukocytes without RNA extraction Cell selection using streptavidin PCR tubes
    CLINICAL BIOCHEMISTRY
    
    M.M. Hamalainen et al., "RT-PCR from eosinophil-depleted leukocytes without RNA extraction Cell selection using streptavidin PCR tubes", CLIN BIOCH, 33(8), 2000, pp. 643-647
25. Liu, L; Abken, H; Pfohler, C; Rappl, G; Tilgen, W; Reinhold, U
    Accumulation of CD4(+)CD7(-) T cells in inflammatory skin lesions: evidence for preferential adhesion to vascular endothelial cells
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    L. Liu et al., "Accumulation of CD4(+)CD7(-) T cells in inflammatory skin lesions: evidence for preferential adhesion to vascular endothelial cells", CLIN EXP IM, 121(1), 2000, pp. 94-99
26. Kraguljac, N; Marisavljevic, D; Jankovic, G; Radosevic, N; Pantic, M; Donfrid, M; Miletic, N; Boskovic, D; Colovic, M
    Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia
    AJCP. American journal of clinical pathology
    
    N. Kraguljac et al., "Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia", AM J CLIN P, 114(1), 2000, pp. 29-34
27. Mastrandrea, F; Cadario, G; Nicotra, MR; Natali, PG
    Hemopoietic progenitor cells in atopic dermatitis skin lesions
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY
    
    F. Mastrandrea et al., "Hemopoietic progenitor cells in atopic dermatitis skin lesions", J INVES ALL, 9(6), 1999, pp. 386-391
28. Zangger, K; Oz, G; Otvos, JD; Armitage, IM
    Three-dimensional solution structure of mouse [Cd-7]-metallothionein-1 by homonuclear and heteronuclear NMR spectroscopy
    PROTEIN SCIENCE
    
    K. Zangger et al., "Three-dimensional solution structure of mouse [Cd-7]-metallothionein-1 by homonuclear and heteronuclear NMR spectroscopy", PROTEIN SCI, 8(12), 1999, pp. 2630-2638
29. Murase, T; Suzuki, R; Tashiro, K; Morishima, Y; Nakamura, S
    Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    T. Murase et al., "Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor", INT J HEMAT, 69(2), 1999, pp. 89-91
30. Saitoh, T; Morimoto, K; Kumagai, T; Saiki, M; Tanaka, M; Aikawa, S; Tsubo, I; Sawada, U; Horie, T
    Therapy-related megakaryoblastic leukemia with pituitary involvement following treatment for non-Hodgkin's lymphoma
    INTERNAL MEDICINE
    
    T. Saitoh et al., "Therapy-related megakaryoblastic leukemia with pituitary involvement following treatment for non-Hodgkin's lymphoma", INTERN MED, 38(11), 1999, pp. 904-909
31. Huang, SY; Tang, JL; Jou, ST; Tsay, W; Hu, CH; Lin, DT; Lin, KS; Lin, KS; Wang, CH; Chen, YC; Shen, MC; Tien, HF
    Minimally differentiated acute myeloid leukemia in Taiwan: predominantly occurs in children less than 3 years and adults between 51 and 70 years
    LEUKEMIA
    
    S.Y. Huang et al., "Minimally differentiated acute myeloid leukemia in Taiwan: predominantly occurs in children less than 3 years and adults between 51 and 70 years", LEUKEMIA, 13(10), 1999, pp. 1506-1512
32. Martin-Henao, GA; Quiroga, R; Sureda, A; Garcia, J
    CD7 expression on CD34+cells from chronic myeloid leukaemia in chronic phase
    AMERICAN JOURNAL OF HEMATOLOGY
    
    G.A. Martin-Henao et al., "CD7 expression on CD34+cells from chronic myeloid leukaemia in chronic phase", AM J HEMAT, 61(3), 1999, pp. 178-186
33. Dummer, R; Nestle, FO; Niederer, E; Ludwig, E; Laine, E; Grundmann, H; Grob, P; Burg, G
    Genotypic, phenotypic and functional analysis of CD4(+)CD7(+) and CD4(+)CD7-T lymphocyte subsets in Sezary syndrome
    ARCHIVES OF DERMATOLOGICAL RESEARCH
    
    R. Dummer et al., "Genotypic, phenotypic and functional analysis of CD4(+)CD7(+) and CD4(+)CD7-T lymphocyte subsets in Sezary syndrome", ARCH DERM R, 291(6), 1999, pp. 307-311
34. Suzuki, R; Nakamura, S
    Malignancies of natural killer (NK) cell precursor: myeloid NK cell precursor acute leukemia and blastic NK cell lymphoma leukemia
    LEUKEMIA RESEARCH
    
    R. Suzuki e S. Nakamura, "Malignancies of natural killer (NK) cell precursor: myeloid NK cell precursor acute leukemia and blastic NK cell lymphoma leukemia", LEUK RES, 23(7), 1999, pp. 615-624
35. Sempowski, GD; Lee, DM; Scearce, RM; Patel, DD; Haynes, BF
    Resistance of CD7-deficient mice to lipopolysaccharide-induced shock syndromes
    JOURNAL OF EXPERIMENTAL MEDICINE
    
    G.D. Sempowski et al., "Resistance of CD7-deficient mice to lipopolysaccharide-induced shock syndromes", J EXP MED, 189(6), 1999, pp. 1011-1016
36. Hill, SJ; Peters, SH; Ayliffe, MJ; Merceica, J; Bansal, AS
    Reduced IL-4 and interferon-gamma (IFN-gamma) expression by CD4 T cells inpatients with chronic lymphocytic leukaemia
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    S.J. Hill et al., "Reduced IL-4 and interferon-gamma (IFN-gamma) expression by CD4 T cells inpatients with chronic lymphocytic leukaemia", CLIN EXP IM, 117(1), 1999, pp. 8-11
37. Tokunaga, Y; Okamura, T; Miyamoto, T; Niho, Y
    False positive reactions for CD7 of blast cells in patients with acute myelogenous leukaemia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    Y. Tokunaga et al., "False positive reactions for CD7 of blast cells in patients with acute myelogenous leukaemia", BR J HAEM, 104(3), 1999, pp. 642-643
38. You, CH; Mackay, EA; Gehrig, PM; Hunziker, PE; Kagi, JHR
    Purification and characterization of recombinant Caenorhabditis elegans metallothionein
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    
    C.H. You et al., "Purification and characterization of recombinant Caenorhabditis elegans metallothionein", ARCH BIOCH, 372(1), 1999, pp. 44-52
39. TIEN HF; WANG CH
    CD7 POSITIVE HEMATOPOIETIC PROGENITORS AND ACUTE MYELOID-LEUKEMIA ANDOTHER MINIMALLY DIFFERENTIATED LEUKEMIA
    Leukemia & lymphoma
    
    H.F. Tien e C.H. Wang, "CD7 POSITIVE HEMATOPOIETIC PROGENITORS AND ACUTE MYELOID-LEUKEMIA ANDOTHER MINIMALLY DIFFERENTIATED LEUKEMIA", Leukemia & lymphoma, 31(1-2), 1998, pp. 93-98
40. SLENTZKESLER KA; HALE LP; KAUFMAN RE
    IDENTIFICATION AND CHARACTERIZATION OF K12 (SECTM1), A NOVEL HUMAN GENE THAT ENCODES A GOLGI-ASSOCIATED PROTEIN WITH TRANSMEMBRANE AND SECRETED ISOFORMS
    Genomics
    
    K.A. Slentzkesler et al., "IDENTIFICATION AND CHARACTERIZATION OF K12 (SECTM1), A NOVEL HUMAN GENE THAT ENCODES A GOLGI-ASSOCIATED PROTEIN WITH TRANSMEMBRANE AND SECRETED ISOFORMS", Genomics, 47(3), 1998, pp. 327-340
41. VENDITTI A; DELPOETA G; BUCCISANO F; TAMBURINI A; COXFRONCILLO MC; ARONICA G; BRUNO A; DELMORO B; EPICENO AM; BATTAGLIA A; FORTE L; POSTORINO M; CORDERO V; SANTINELLI S; AMADORI S
    PROGNOSTIC RELEVANCE OF THE EXPRESSION OF TDT AND CD7 IN 335 CASES OFACUTE MYELOID-LEUKEMIA
    Leukemia
    
    A. Venditti et al., "PROGNOSTIC RELEVANCE OF THE EXPRESSION OF TDT AND CD7 IN 335 CASES OFACUTE MYELOID-LEUKEMIA", Leukemia, 12(7), 1998, pp. 1056-1063
42. SAXENA A; SHERIDAN DP; CARD RT; MCPEEK AM; MEWDELL CC; SKINNIDER LF
    BIOLOGIC AND CLINICAL-SIGNIFICANCE OF CD7 EXPRESSION IN ACUTE MYELOID-LEUKEMIA
    American journal of hematology
    
    A. Saxena et al., "BIOLOGIC AND CLINICAL-SIGNIFICANCE OF CD7 EXPRESSION IN ACUTE MYELOID-LEUKEMIA", American journal of hematology, 58(4), 1998, pp. 278-284
43. HALLER C; KIESSLING F; KUBLER W
    POLARIZED EXPRESSION OF HETEROLOGOUS MEMBRANE-PROTEINS TRANSFECTED INA HUMAN ENDOTHELIAL-DERIVED CELL-LINE
    European journal of cell biology
    
    C. Haller et al., "POLARIZED EXPRESSION OF HETEROLOGOUS MEMBRANE-PROTEINS TRANSFECTED INA HUMAN ENDOTHELIAL-DERIVED CELL-LINE", European journal of cell biology, 75(4), 1998, pp. 353-361
44. LEE DM; STAATS HF; SUNDY JS; PATEL DD; SEMPOWSKI GD; SCEARCE RM; JONES DM; HAYNES BF
    IMMUNOLOGICAL CHARACTERIZATION OF CD7-DEFICIENT MICE
    The Journal of immunology
    
    D.M. Lee et al., "IMMUNOLOGICAL CHARACTERIZATION OF CD7-DEFICIENT MICE", The Journal of immunology, 160(12), 1998, pp. 5749-5756
45. TOKUNAGA Y; MIYAMOTO T; OKAMURA T; ETO T; GONDO H; KAMIMURA T; OKAMURA S; NIHO Y
    EFFECT OF THROMBOPOIETIN ON PROLIFERATION OF BLASTS FROM CD7-POSITIVEACUTE MYELOGENOUS LEUKEMIA
    British Journal of Haematology
    
    Y. Tokunaga et al., "EFFECT OF THROMBOPOIETIN ON PROLIFERATION OF BLASTS FROM CD7-POSITIVEACUTE MYELOGENOUS LEUKEMIA", British Journal of Haematology, 102(5), 1998, pp. 1232-1240
46. MYERS DE; JUN X; CLEMENTSON D; DONELSON R; SICHENEDER A; HOFFMAN N; BELL K; SARQUIS M; LANGLIE MC; TURNER N; UCKUN FM
    LARGE-SCALE MANUFACTURING OF TXU(ANTI-CD7)-POKEWEED ANTIVIRAL PROTEIN(PAP) IMMUNOCONJUGATE FOR CLINICAL-TRIALS
    Leukemia & lymphoma
    
    D.E. Myers et al., "LARGE-SCALE MANUFACTURING OF TXU(ANTI-CD7)-POKEWEED ANTIVIRAL PROTEIN(PAP) IMMUNOCONJUGATE FOR CLINICAL-TRIALS", Leukemia & lymphoma, 27(3-4), 1997, pp. 275-302
47. FRANKEL AE; LAVER JH; WILLINGHAM MC; BURNS LJ; KERSEY JH; VALLERA DA
    THERAPY OF PATIENTS WITH T-CELL LYMPHOMAS AND LEUKEMIAS USING AN ANTI-CD7 MONOCLONAL-ANTIBODY RICIN-A CHAIN IMMUNOTOXIN
    Leukemia & lymphoma
    
    A.E. Frankel et al., "THERAPY OF PATIENTS WITH T-CELL LYMPHOMAS AND LEUKEMIAS USING AN ANTI-CD7 MONOCLONAL-ANTIBODY RICIN-A CHAIN IMMUNOTOXIN", Leukemia & lymphoma, 26(3-4), 1997, pp. 287-298
48. HUANG ZX; GU WQ; ZHENG Q; LIU F; SUN YJ
    CONFORMATIONAL-CHANGES AND SURFACE BINDING PROPERTY OF RAT-LIVER CD5ZN2-METALLOTHIONEIN
    Chinese journal of chemistry
    
    Z.X. Huang et al., "CONFORMATIONAL-CHANGES AND SURFACE BINDING PROPERTY OF RAT-LIVER CD5ZN2-METALLOTHIONEIN", Chinese journal of chemistry, 15(5), 1997, pp. 385-394
49. BONILLA FA; KOKRON CM; SWINTON P; GEHA RS
    TARGETED GENE DISRUPTION OF MURINE CD7
    International immunology
    
    F.A. Bonilla et al., "TARGETED GENE DISRUPTION OF MURINE CD7", International immunology, 9(12), 1997, pp. 1875-1883
50. HATANO Y; MIURA I; HORIUCHI T; HOSHI N; NANJOU H; MASUDA H; MIURA AB
    CEREBELLAR MYELOBLASTOMA FORMATION IN CD7-POSITIVE NEURAL CELL-ADHESION MOLECULE (CD56)-POSITIVE ACUTE MYELOGENOUS LEUKEMIA (M1)
    Annals of hematology
    
    Y. Hatano et al., "CEREBELLAR MYELOBLASTOMA FORMATION IN CD7-POSITIVE NEURAL CELL-ADHESION MOLECULE (CD56)-POSITIVE ACUTE MYELOGENOUS LEUKEMIA (M1)", Annals of hematology, 75(3), 1997, pp. 125-128
51. MIZUTANI M; MIWA H; TAKAHASHI T; KATOH K; SHIKAMI M; KATAYAMA N; SHIKU H; KITA K
    CELLULAR CHARACTERISTICS OF ACUTE-LEUKEMIA CELLS SIMULTANEOUSLY EXPRESSING CD13 CD33, CD7 AND CD19/
    International journal of hematology
    
    M. Mizutani et al., "CELLULAR CHARACTERISTICS OF ACUTE-LEUKEMIA CELLS SIMULTANEOUSLY EXPRESSING CD13 CD33, CD7 AND CD19/", International journal of hematology, 66(4), 1997, pp. 479-491
52. ONO K; YOSHIDA T; TSUCHIYA K; NAKAZATO S; NAGUMO F; SHIMAMOTO Y
    A NEW STRATEGY FOR TREATING PATIENTS WITH CD7(-), CD8(-) ACUTE LYMPHOBLASTIC-LEUKEMIA(), CD4()
    European journal of haematology
    
    K. Ono et al., "A NEW STRATEGY FOR TREATING PATIENTS WITH CD7(-), CD8(-) ACUTE LYMPHOBLASTIC-LEUKEMIA(), CD4()", European journal of haematology, 58(2), 1997, pp. 130-132
53. MARTI RM; HAUSMANN G; ESTRACH T; CID MC; PALOU J; HERRERO C; MASCARO JM
    T-CELL POPULATION OF PRIMARY AND SECONDARY CUTANEOUS B-CELL LYMPHOMASDOES NOT EXPRESS THE CUTANEOUS LYMPHOCYTE-ASSOCIATED ANTIGEN (CLA)
    Archives of dermatological research
    
    R.M. Marti et al., "T-CELL POPULATION OF PRIMARY AND SECONDARY CUTANEOUS B-CELL LYMPHOMASDOES NOT EXPRESS THE CUTANEOUS LYMPHOCYTE-ASSOCIATED ANTIGEN (CLA)", Archives of dermatological research, 289(6), 1997, pp. 327-330
54. REINHOLD U; ABKEN H
    CD4(-) T-CELLS - A SEPARATE SUBPOPULATION OF MEMORY T-CELLS()CD7()
    Journal of clinical immunology
    
    U. Reinhold e H. Abken, "CD4(-) T-CELLS - A SEPARATE SUBPOPULATION OF MEMORY T-CELLS()CD7()", Journal of clinical immunology, 17(4), 1997, pp. 265-271
55. SHI GP; WEH HJ; DUHRSEN U; ZELLER W; HOSSFELD DK
    CHROMOSOMAL ABNORMALITY INV(3)(Q21Q26) ASSOCIATED WITH MULTILINEAGE HEMATOPOIETIC PROGENITOR CELLS IN HEMATOPOIETIC MALIGNANCIES
    Cancer genetics and cytogenetics
    
    G.P. Shi et al., "CHROMOSOMAL ABNORMALITY INV(3)(Q21Q26) ASSOCIATED WITH MULTILINEAGE HEMATOPOIETIC PROGENITOR CELLS IN HEMATOPOIETIC MALIGNANCIES", Cancer genetics and cytogenetics, 96(1), 1997, pp. 58-63
56. NAGANO M; KIMURA N; AKIYOSHI T; NISHIMURA J; KOZURU M; OKAMURA J; KATSUNO M; YOSHIDA T; TAKESHITA M; TACHIBANA K; OHSHIMA K; KIKUCHI M
    T-STEM CELL LEUKEMIA LYMPHOMA WITH BOTH MYELOID LINEAGE CONVERSION AND T-SPECIFIC DELTA-RECOMBINATION/
    Leukemia research
    
    M. Nagano et al., "T-STEM CELL LEUKEMIA LYMPHOMA WITH BOTH MYELOID LINEAGE CONVERSION AND T-SPECIFIC DELTA-RECOMBINATION/", Leukemia research, 21(8), 1997, pp. 763-773
57. BROWN PD; JURLANDER J; PEDERSENBJERGAARD J; VICTOR MA; GEISLER CH
    THE PROGNOSTIC-SIGNIFICANCE OF CHROMOSOMAL ANALYSIS AND IMMUNOPHENOTYPING IN 117 PATIENTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA
    Leukemia research
    
    P.D. Brown et al., "THE PROGNOSTIC-SIGNIFICANCE OF CHROMOSOMAL ANALYSIS AND IMMUNOPHENOTYPING IN 117 PATIENTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA", Leukemia research, 21(10), 1997, pp. 985-995
58. CHAN ASH; MOBLEY JL; FIELDS GB; SHIMIZU Y
    CD7-MEDIATED REGULATION OF INTEGRIN ADHESIVENESS ON HUMAN T-CELLS INVOLVES TYROSINE PHOSPHORYLATION-DEPENDENT ACTIVATION OF PHOSPHATIDYLINOSITOL 3-KINASE
    The Journal of immunology
    
    A.S.H. Chan et al., "CD7-MEDIATED REGULATION OF INTEGRIN ADHESIVENESS ON HUMAN T-CELLS INVOLVES TYROSINE PHOSPHORYLATION-DEPENDENT ACTIVATION OF PHOSPHATIDYLINOSITOL 3-KINASE", The Journal of immunology, 159(2), 1997, pp. 934-942
59. ELDIN P; PAUZA ME; HIEDA Y; LIN GF; MURTAUGH MP; PENTEL PR; PENNELL CA
    HIGH-LEVEL SECRETION OF 2 ANTIBODY SINGLE-CHAIN FV FRAGMENTS BY PICHIA-PASTORIS
    Journal of immunological methods
    
    P. Eldin et al., "HIGH-LEVEL SECRETION OF 2 ANTIBODY SINGLE-CHAIN FV FRAGMENTS BY PICHIA-PASTORIS", Journal of immunological methods, 201(1), 1997, pp. 67-75
60. MA SK; LIE AKW; AU WY; WAN TSK; CHAN LC
    CD7(-LEUKEMIA WITH MATURE LYMPHOID BLAST MORPHOLOGY, MARROW BASOPHILIA AND T(4-12)(Q12-P13)() ACUTE MYELOID)
    British Journal of Haematology
    
    S.K. Ma et al., "CD7(-LEUKEMIA WITH MATURE LYMPHOID BLAST MORPHOLOGY, MARROW BASOPHILIA AND T(4-12)(Q12-P13)() ACUTE MYELOID)", British Journal of Haematology, 99(4), 1997, pp. 978-980
61. EGUCHI M; HARADA H; SUZUKAWA K; MORISHITA K; KAMADA N
    T(4-12)(Q11-P13) IN A CD7-NEGATIVE ACUTE MYELOID-LEUKEMIA - REPLY
    British Journal of Haematology
    
    M. Eguchi et al., "T(4-12)(Q11-P13) IN A CD7-NEGATIVE ACUTE MYELOID-LEUKEMIA - REPLY", British Journal of Haematology, 96(1), 1997, pp. 211-212
62. YAGI H; TOKURA Y; MATSUSHITA K; HANAOKA K; FURUKAWA F; TAKIGAWA M
    WELLS-SYNDROME - A PATHOGENIC ROLE FOR CIRCULATING CD4(-) T-CELLS EXPRESSING INTERLEUKIN-5 MESSENGER-RNA()CD7()
    British journal of dermatology
    
    H. Yagi et al., "WELLS-SYNDROME - A PATHOGENIC ROLE FOR CIRCULATING CD4(-) T-CELLS EXPRESSING INTERLEUKIN-5 MESSENGER-RNA()CD7()", British journal of dermatology, 136(6), 1997, pp. 918-923
63. FLAVELL DJ; BOEHM DA; NOSS A; FLAVELL SU
    COMPARISON OF THE POTENCY AND THERAPEUTIC EFFICACY OF THE ANTI-CD7 IMMUNOTOXIN HB2-SAPORIN CONSTRUCTED WITH ONE OR 2 SAPORIN MOIETIES PER IMMUNOTOXIN MOLECULE
    British Journal of Cancer
    
    D.J. Flavell et al., "COMPARISON OF THE POTENCY AND THERAPEUTIC EFFICACY OF THE ANTI-CD7 IMMUNOTOXIN HB2-SAPORIN CONSTRUCTED WITH ONE OR 2 SAPORIN MOIETIES PER IMMUNOTOXIN MOLECULE", British Journal of Cancer, 75(7), 1997, pp. 1035-1043
64. MIWA H; NAKASE K; KITA K
    BIOLOGICAL CHARACTERISTICS OF CD7(-LEUKEMIA() ACUTE)
    Leukemia & lymphoma
    
    H. Miwa et al., "BIOLOGICAL CHARACTERISTICS OF CD7(-LEUKEMIA() ACUTE)", Leukemia & lymphoma, 21(3-4), 1996, pp. 239-244
65. LEE DM; PATEL DD; PENDERGAST AM; HAYNES BF
    FUNCTIONAL ASSOCIATION OF CD7 WITH PHOSPHATIDYLINOSITOL 3-KINASE - INTERACTION VIA A YEDM MOTIF
    International immunology
    
    D.M. Lee et al., "FUNCTIONAL ASSOCIATION OF CD7 WITH PHOSPHATIDYLINOSITOL 3-KINASE - INTERACTION VIA A YEDM MOTIF", International immunology, 8(8), 1996, pp. 1195-1203
66. AMADORI S; VENDITTI A; DELPOETA G; STASI R; BUCCISANO F; BRUNO A; TAMBURINI A; COX MC; MAFFEI L; ARONICA G; SIMONE MD; ADORNO G; MASI M; TRIBALTO M; PAPA G
    MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) - A DISTINCTCLINICO-BIOLOGIC ENTITY WITH POOR-PROGNOSIS
    Annals of hematology
    
    S. Amadori et al., "MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) - A DISTINCTCLINICO-BIOLOGIC ENTITY WITH POOR-PROGNOSIS", Annals of hematology, 72(4), 1996, pp. 208-215
67. KIMURA N; AKIYOSHI T; UCHIDA T; OKAMURA J; KOZURU M; NISHIMURA J; OHYASHIKI JH; KIKUCHI M; NIHO Y; OKUMURA M
    HIGH PREVALENCE OF T-CELL RECEPTOR D-DELTA-2(D-DELTA)J-DELTA REARRANGEMENT IN CD7-POSITIVE EARLY T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
    Leukemia
    
    N. Kimura et al., "HIGH PREVALENCE OF T-CELL RECEPTOR D-DELTA-2(D-DELTA)J-DELTA REARRANGEMENT IN CD7-POSITIVE EARLY T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA", Leukemia, 10(4), 1996, pp. 650-657
68. FERRARA F; SCOGNAMIGLIO M; DINOTO R; SCHIAVONE EM; POGGI V; FIORILLO A; LIBERTINI R; VICAN L; DELVECCHIO L; SEBASTIO L
    INTERSTITIAL 9Q DELETION IS ASSOCIATED WITH CD7(-LEUKEMIA OF MYELOID AND T-LYMPHOID LINEAGE() ACUTE)
    Leukemia
    
    F. Ferrara et al., "INTERSTITIAL 9Q DELETION IS ASSOCIATED WITH CD7(-LEUKEMIA OF MYELOID AND T-LYMPHOID LINEAGE() ACUTE)", Leukemia, 10(12), 1996, pp. 1990-1992
69. SAHIN B; PAYDAS S; HAZAR B
    IS CONCOMITANT HIGH CD7 AND LOW PRB EXPRESSION ASSOCIATED WITH CENTRAL-NERVOUS-SYSTEM INVOLVEMENT IN ACUTE-LEUKEMIA
    The Cancer journal
    
    B. Sahin et al., "IS CONCOMITANT HIGH CD7 AND LOW PRB EXPRESSION ASSOCIATED WITH CENTRAL-NERVOUS-SYSTEM INVOLVEMENT IN ACUTE-LEUKEMIA", The Cancer journal, 9(4), 1996, pp. 192-195
70. HARMON CB; WITZIG TE; KATZMANN JA; PITTELKOW MR
    DETECTION OF CIRCULATING T-CELLS WITH CD4(-) IMMUNOPHENOTYPE IN PATIENTS WITH BENIGN AND MALIGNANT LYMPHOPROLIFERATIVE DERMATOSES()CD7()
    Journal of the American Academy of Dermatology
    
    C.B. Harmon et al., "DETECTION OF CIRCULATING T-CELLS WITH CD4(-) IMMUNOPHENOTYPE IN PATIENTS WITH BENIGN AND MALIGNANT LYMPHOPROLIFERATIVE DERMATOSES()CD7()", Journal of the American Academy of Dermatology, 35(3), 1996, pp. 404-410
71. YAGI H; TOKURA Y; FURUKAWA F; TAKIGAWA M
    CD7-POSITIVE SEZARY-SYNDROME WITH A TH1 CYTOKINE PROFILE
    Journal of the American Academy of Dermatology
    
    H. Yagi et al., "CD7-POSITIVE SEZARY-SYNDROME WITH A TH1 CYTOKINE PROFILE", Journal of the American Academy of Dermatology, 34(2), 1996, pp. 368-374
72. WATANABE A; KAWACHI Y; NISHIHARA T; UCHIDA T; SETSU K; HIKIJI K
    EXTRA Y-CHROMOSOME IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
    Cancer genetics and cytogenetics
    
    A. Watanabe et al., "EXTRA Y-CHROMOSOME IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA", Cancer genetics and cytogenetics, 89(1), 1996, pp. 85-87
73. KTORZA S; BLANC C; LAURENT C; SARUN S; VERPILLEUX MP; DEBRE P; SCHMITT C
    COMPLETE TCR-DELTA REARRANGEMENTS AND PARTIAL (D-J) RECOMBINATION OF THE TCR-BETA LOCUS IN CD34(-BLOOD - EVIDENCE FOR T-CELL LINEAGE COMMITMENT()7(+) PRECURSORS FROM HUMAN CORD)
    The Journal of immunology
    
    S. Ktorza et al., "COMPLETE TCR-DELTA REARRANGEMENTS AND PARTIAL (D-J) RECOMBINATION OF THE TCR-BETA LOCUS IN CD34(-BLOOD - EVIDENCE FOR T-CELL LINEAGE COMMITMENT()7(+) PRECURSORS FROM HUMAN CORD)", The Journal of immunology, 156(11), 1996, pp. 4120-4127
74. REINHOLD U; LIU L; SESTERHENN J; ABKEN H
    CD7-NEGATIVE T-CELLS REPRESENT A SEPARATE DIFFERENTIATION PATHWAY IN A SUBSET OF POSTTHYMIC HELPER T-CELLS
    Immunology
    
    U. Reinhold et al., "CD7-NEGATIVE T-CELLS REPRESENT A SEPARATE DIFFERENTIATION PATHWAY IN A SUBSET OF POSTTHYMIC HELPER T-CELLS", Immunology, 89(3), 1996, pp. 391-396
75. REINHOLD U; LIU L; SESTERHENN J; SCHNAUTZ S; ABKEN H
    THE CD7(-) T-CELL SUBSET REPRESENTS THE MAJORITY OF IL-5-SECRETING CELLS WITHIN CD4(-) T-CELLS() CD45RA()
    Clinical and experimental immunology
    
    U. Reinhold et al., "THE CD7(-) T-CELL SUBSET REPRESENTS THE MAJORITY OF IL-5-SECRETING CELLS WITHIN CD4(-) T-CELLS() CD45RA()", Clinical and experimental immunology, 106(3), 1996, pp. 555-559
76. BAUM W; STEININGER H; BAIR HJ; BECKER W; HANSENHAGGE TE; KRESSEL M; KREMMER E; KALDEN JR; GRAMATZKI M
    THERAPY WITH CD7 MONOCLONAL-ANTIBODY TH-69 IS HIGHLY EFFECTIVE FOR XENOGRAFTED HUMAN T-CELL ALL
    British Journal of Haematology
    
    W. Baum et al., "THERAPY WITH CD7 MONOCLONAL-ANTIBODY TH-69 IS HIGHLY EFFECTIVE FOR XENOGRAFTED HUMAN T-CELL ALL", British Journal of Haematology, 95(2), 1996, pp. 327-338
77. TIEN HF; CHOU CC; WANG CH; CHANG CH; HSING CC
    PUTATIVE NORMAL COUNTERPARTS OF LEUKEMIC-CELLS FROM CD7-POSITIVE ACUTE MYELOID-LEUKEMIA CAN BE DEMONSTRATED IN HUMAN HEMATOPOIETIC TISSUES
    British Journal of Haematology
    
    H.F. Tien et al., "PUTATIVE NORMAL COUNTERPARTS OF LEUKEMIC-CELLS FROM CD7-POSITIVE ACUTE MYELOID-LEUKEMIA CAN BE DEMONSTRATED IN HUMAN HEMATOPOIETIC TISSUES", British Journal of Haematology, 94(3), 1996, pp. 501-506
78. GINALDI L; MATUTES E; FARAHAT N; DEMARTINIS M; MORILLA R; CATOVSKY D
    DIFFERENTIAL EXPRESSION OF CD3 AND CD7 IN T-CELL MALIGNANCIES - A QUANTITATIVE STUDY BY FLOW-CYTOMETRY
    British Journal of Haematology
    
    L. Ginaldi et al., "DIFFERENTIAL EXPRESSION OF CD3 AND CD7 IN T-CELL MALIGNANCIES - A QUANTITATIVE STUDY BY FLOW-CYTOMETRY", British Journal of Haematology, 93(4), 1996, pp. 921-927
79. DINOTO R; LOPARDO C; SCHIAVONE EM; MANZO C; VACCA C; FERRARA F; DELVECCHIO L
    STEM-CELL FACTOR-RECEPTOR (C-KIT, CD117) IS EXPRESSED ON BLAST CELLS FROM MOST IMMATURE TYPES OF ACUTE MYELOID MALIGNANCIES BUT IS ALSO A CHARACTERISTIC OF A SUBSET OF ACUTE PROMYELOCYTIC LEUKEMIA
    British Journal of Haematology
    
    R. Dinoto et al., "STEM-CELL FACTOR-RECEPTOR (C-KIT, CD117) IS EXPRESSED ON BLAST CELLS FROM MOST IMMATURE TYPES OF ACUTE MYELOID MALIGNANCIES BUT IS ALSO A CHARACTERISTIC OF A SUBSET OF ACUTE PROMYELOCYTIC LEUKEMIA", British Journal of Haematology, 92(3), 1996, pp. 562-564
80. BOGEN SA; PELLEY D; CHARIF M; MCCUSKER M; KOH H; FOSS F; GARIFALLOU M; ARKIN C; ZUCKERFRANKLIN D
    IMMUNOPHENOTYPIC IDENTIFICATION OF SEZARY CELLS IN PERIPHERAL-BLOOD
    American journal of clinical pathology
    
    S.A. Bogen et al., "IMMUNOPHENOTYPIC IDENTIFICATION OF SEZARY CELLS IN PERIPHERAL-BLOOD", American journal of clinical pathology, 106(6), 1996, pp. 739-748
81. LAUNDER TM; BRAY RA; STEMPORA L; CHENGGIS ML; FARHI DC
    LYMPHOID-ASSOCIATED ANTIGEN EXPRESSION BY ACUTE MYELOID-LEUKEMIA
    American journal of clinical pathology
    
    T.M. Launder et al., "LYMPHOID-ASSOCIATED ANTIGEN EXPRESSION BY ACUTE MYELOID-LEUKEMIA", American journal of clinical pathology, 106(2), 1996, pp. 185-191
82. LAURIA F; RASPADORI D; VENTURA MA; RONDELLI D; TESTONI N; TOSI P; MICHIELI M; DAMIANI D; MOTTA MR; TURA S
    THE PRESENCE OF LYMPHOID-ASSOCIATED ANTIGENS IN ADULT ACUTE MYELOID-LEUKEMIA IS DEVOID OF PROGNOSTIC RELEVANCE
    Stem cells
    
    F. Lauria et al., "THE PRESENCE OF LYMPHOID-ASSOCIATED ANTIGENS IN ADULT ACUTE MYELOID-LEUKEMIA IS DEVOID OF PROGNOSTIC RELEVANCE", Stem cells, 13(4), 1995, pp. 428-434
83. BARCENA A; MUENCH MO; RONCAROLO MG; SPITS H
    TRACING THE EXPRESSION OF CD7 AND OTHER ANTIGENS DURING T-CELL AND MYELOID-CELL DIFFERENTIATION IN THE HUMAN FETAL LIVER AND THYMUS
    Leukemia & lymphoma
    
    A. Barcena et al., "TRACING THE EXPRESSION OF CD7 AND OTHER ANTIGENS DURING T-CELL AND MYELOID-CELL DIFFERENTIATION IN THE HUMAN FETAL LIVER AND THYMUS", Leukemia & lymphoma, 17(1-2), 1995, pp. 1-11
84. DELPOETA G; STASI R; VENDITTI A; COX C; ARONICA G; MASI M; BRUNO A; SIMONE MD; BUCCISANO F; PAPA G
    CD7 EXPRESSION IN ACUTE MYELOID-LEUKEMIA
    Leukemia & lymphoma
    
    G. Delpoeta et al., "CD7 EXPRESSION IN ACUTE MYELOID-LEUKEMIA", Leukemia & lymphoma, 17(1-2), 1995, pp. 111-119
85. CHOY EHS; KINGSLEY GH; PANAYI GS
    T-CELL REGULATION
    Bailliere's clinical rheumatology
    
    E.H.S. Choy et al., "T-CELL REGULATION", Bailliere's clinical rheumatology, 9(4), 1995, pp. 653-671
86. HALLER C; ALPER SL
    ASSESSMENT OF HETEROLOGOUS MEMBRANE-PROTEIN POLARITY IN TRANSIENTLY TRANSFECTED MDCK CELLS (VOL 17, PG 71, 1995)
    Cytotechnology
    
    C. Haller e S.L. Alper, "ASSESSMENT OF HETEROLOGOUS MEMBRANE-PROTEIN POLARITY IN TRANSIENTLY TRANSFECTED MDCK CELLS (VOL 17, PG 71, 1995)", Cytotechnology, 18(3), 1995, pp. 235
87. HALLER C; ALPER SL
    ASSESSMENT OF HETEROLOGOUS MEMBRANE-PROTEIN POLARITY IN TRANSIENTLY TRANSFECTED MDCK CELLS
    Cytotechnology
    
    C. Haller e S.L. Alper, "ASSESSMENT OF HETEROLOGOUS MEMBRANE-PROTEIN POLARITY IN TRANSIENTLY TRANSFECTED MDCK CELLS", Cytotechnology, 17(2), 1995, pp. 71-82
88. KORNBLAU SM; THALL P; HUH YO; ESTEY E; ANDREEFF M
    ANALYSIS OF CD7 EXPRESSION IN ACUTE MYELOGENOUS LEUKEMIA - MARTINGALERESIDUAL PLOTS COMBINED WITH OPTIMAL CUTPOINT ANALYSIS REVEALS ABSENCE OF PROGNOSTIC-SIGNIFICANCE
    Leukemia
    
    S.M. Kornblau et al., "ANALYSIS OF CD7 EXPRESSION IN ACUTE MYELOGENOUS LEUKEMIA - MARTINGALERESIDUAL PLOTS COMBINED WITH OPTIMAL CUTPOINT ANALYSIS REVEALS ABSENCE OF PROGNOSTIC-SIGNIFICANCE", Leukemia, 9(10), 1995, pp. 1735-1741
89. BOWCOCK AM
    GENETIC-LOCUS FOR PSORIASIS IDENTIFIED
    Annals of medicine
    
    A.M. Bowcock, "GENETIC-LOCUS FOR PSORIASIS IDENTIFIED", Annals of medicine, 27(2), 1995, pp. 183-186
90. SASAKI S; FUKAWA H; MOTOMURA S; MOHRI H; OHKUBO T; KATAYAMA R
    SUCCESSFUL TREATMENT OF CD7-POSITIVE, UNDIFFERENTIATED ACUTE-LEUKEMIAWITH RECOMBINANT INTERFERON-ALPHA
    American journal of hematology
    
    S. Sasaki et al., "SUCCESSFUL TREATMENT OF CD7-POSITIVE, UNDIFFERENTIATED ACUTE-LEUKEMIAWITH RECOMBINANT INTERFERON-ALPHA", American journal of hematology, 48(3), 1995, pp. 203-204
91. HORNEFF G; BURMESTER GR
    MONOCLONAL-ANTIBODIES FOR IMMUNOINTERVENT ION IN RHEUMATOID-ARTHRITIS
    Zeitschrift fur Rheumatologie
    
    G. Horneff e G.R. Burmester, "MONOCLONAL-ANTIBODIES FOR IMMUNOINTERVENT ION IN RHEUMATOID-ARTHRITIS", Zeitschrift fur Rheumatologie, 54(2), 1995, pp. 96-104
92. SMITH KJ; SKELTON HG; CHU WS; YEAGER J; ANGRITT P; WAGNER KF
    DECREASED CD7 EXPRESSION IN CUTANEOUS INFILTRATES OF HIV-1 PLUS PATIENTS
    The American journal of dermatopathology
    
    K.J. Smith et al., "DECREASED CD7 EXPRESSION IN CUTANEOUS INFILTRATES OF HIV-1 PLUS PATIENTS", The American journal of dermatopathology, 17(6), 1995, pp. 564-569
93. WARD SG; PARRY R; LEFEUVRE C; SANSOM DM; WESTWICK J; LAZAROVITS AI
    ANTIBODY LIGATION OF CD7 LEADS TO ASSOCIATION WITH PHOSPHOINOSITIDE 3-KINASE AND PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE FORMATION IN T-LYMPHOCYTES
    European Journal of Immunology
    
    S.G. Ward et al., "ANTIBODY LIGATION OF CD7 LEADS TO ASSOCIATION WITH PHOSPHOINOSITIDE 3-KINASE AND PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE FORMATION IN T-LYMPHOCYTES", European Journal of Immunology, 25(2), 1995, pp. 502-507
94. HARADA H; ASOU H; KYO T; ASAOKU H; IWATO K; DOHY H; ODA K; HARADA Y; KITA K; KAMADA N
    A SPECIFIC CHROMOSOME ABNORMALITY OF T(4-12)(Q11-12-P13) IN CD7(-LEUKEMIA() ACUTE)
    British Journal of Haematology
    
    H. Harada et al., "A SPECIFIC CHROMOSOME ABNORMALITY OF T(4-12)(Q11-12-P13) IN CD7(-LEUKEMIA() ACUTE)", British Journal of Haematology, 90(4), 1995, pp. 850-854
95. CHANG KL; WEISS LM
    CD7 - A REVIEW
    Applied immunohistochemistry
    
    K.L. Chang e L.M. Weiss, "CD7 - A REVIEW", Applied immunohistochemistry, 2(3), 1994, pp. 146-156
96. DELPOETA G; STASI R; VENDITTI A; SUPPO G; ARONICA G; BRUNO A; MASI M; TABILIO A; PAPA G
    PROGNOSTIC VALUE OF CELL MARKER ANALYSIS IN DE-NOVO ACUTE MYELOID-LEUKEMIA
    Leukemia
    
    G. Delpoeta et al., "PROGNOSTIC VALUE OF CELL MARKER ANALYSIS IN DE-NOVO ACUTE MYELOID-LEUKEMIA", Leukemia, 8(3), 1994, pp. 388-394
97. YONEDA N; TATSUMI E; TESHIGAWARA K; NAGATA S; NAGANO T; KISHIMOTO Y; KIMURA T; YASUNAGA K; YAMAGUCHI N
    LINEAGE DETERMINATION OF CD7- CD2- AND CD7+ CD5+ CD2- LYMPHOBLASTS - STUDIES ON PHENOTYPE, GENOTYPE, AND GENE-EXPRESSION OF MYELOPEROXIDASECD3-EPSILON, AND CD3-DELTA( CD5)
    American journal of hematology
    
    N. Yoneda et al., "LINEAGE DETERMINATION OF CD7- CD2- AND CD7+ CD5+ CD2- LYMPHOBLASTS - STUDIES ON PHENOTYPE, GENOTYPE, AND GENE-EXPRESSION OF MYELOPEROXIDASECD3-EPSILON, AND CD3-DELTA( CD5)", American journal of hematology, 45(4), 1994, pp. 310-320
98. KWONG YL
    TRANSIENT ABNORMAL MYELOPOIESIS IN DOWNS-SYNDROME NEONATES
    The American journal of pediatric hematology/oncology
    
    Y.L. Kwong, "TRANSIENT ABNORMAL MYELOPOIESIS IN DOWNS-SYNDROME NEONATES", The American journal of pediatric hematology/oncology, 16(4), 1994, pp. 387-388
99. SHIMAMOTO T; OHYASHIKI JH; OHYASHIKI K; KAWAKUBO K; INATOMI Y; FUJIEDA H; NAKAZAWA S; KIMURA N; MIYAUCHI J; TOYAMA K
    CLINICAL AND BIOLOGIC CHARACTERISTICS OF CD7-LEUKEMIA - OUR EXPERIENCE AND LITERATURE-REVIEW( ACUTE MYELOID)
    Cancer genetics and cytogenetics
    
    T. Shimamoto et al., "CLINICAL AND BIOLOGIC CHARACTERISTICS OF CD7-LEUKEMIA - OUR EXPERIENCE AND LITERATURE-REVIEW( ACUTE MYELOID)", Cancer genetics and cytogenetics, 73(1), 1994, pp. 69-74
100. NAKASE K; KITA K; ANAZAWA H; HOSHINO K; SHIRAKAWA S; TANAKA I; TSUDO M
     INDUCTION OF INTERLEUKIN-2 RECEPTOR-ALPHA CHAIN EXPRESSION ON IMMATURE ACUTE MYELOCYTIC-LEUKEMIA CELLS
     Leukemia research
     
     K. Nakase et al., "INDUCTION OF INTERLEUKIN-2 RECEPTOR-ALPHA CHAIN EXPRESSION ON IMMATURE ACUTE MYELOCYTIC-LEUKEMIA CELLS", Leukemia research, 18(4), 1994, pp. 269-274